ScopusElsevier Scopus
Status
Active
Coverage
2024–2025; 2007-2022
Source type
Journal
Open access
No
CiteScore
0.3
Best quartile
Q4 · 6th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 399 / 428 | 6th | Q4 |
| Pharmacology (medical) | 260 / 278 | 6th | Q4 |
Cancer and Chemotherapy Reviews
ISSN 1885-740X · 2339-8728
Publisher: Permanyer Publications
Scopus · Q4
Is Cancer and Chemotherapy Reviews indexed in Scopus? Yes — actively indexed in Scopus, coverage 2024–2025; 2007-2022, best quartile Q4, CiteScore 0.3.
Is Cancer and Chemotherapy Reviews in Web of Science? No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Cancer and Chemotherapy Reviews open access? No — it is not registered as an open-access journal in DOAJ or Scopus.
0.3
CiteScore 2025
Scopus
Q4
Best quartile
6th percentile
1
Indexed in
major index
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
Not listed in Web of Science.
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Checking DOAJ…
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Official sources & links
Related journals
Explore this journal in the interactive dashboard →
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.